Oct
15
Death by democracy
We had a call this month with an SVP who's taken 11 compounds into clinic, across 6 biotechs.
3 min read
Latest
Sep
29
Federated data lakes in biopharma: why “just put everything in one place” doesn’t work.
In most biopharma organizations, the data story is the same.
You have information scattered across every imaginable system: LIMS, ELNs,
3 min read
Sep
18
The case for R&D observability
Why is it so hard to get answers to pretty straightforward questions, when it comes to biotech data? And what
4 min read
Aug
19
Breaking the “me too” drug cycle in biotech
A significant limitation of AI-driven biotech has been the training data. With so many models drawing on the same pool
4 min read
Aug
07
Productivity is never linear
Cutting out two hours often means saving two weeks. Below, we cover why productivity gains can be such a powerful
4 min read
Jul
16
Every day counts in biotech R&D
When I was seven years old, my mom was diagnosed with leukemia. We were a freshly immigrated family, still figuring
3 min read
Jul
01
What your biotech engineering team should never build
As a biotech company, every resource - minute, dollar, and FTE focus - counts in your race to reach market.
5 min read
Jun
09
Driving commercial success in biopharma: in conversation with Paul Sekhri
What does it take to effectively commercialize a drug? How can biotech leaders successfully navigate this long, winding, and expensive
4 min read
Jun
04
Biotech markets are down. So what?
The most misguided assumption in biotech investing right now is that tough markets hurt everyone equally.
We've been
4 min read
May
22
How CROs reshaped biotech and why it matters today
Biotech today runs on an interconnected web of partners: CROs, CDMOs, academic labs, and startup biotechs all working in tandem.
5 min read